Apnimed Reports Inducement Grants
Apnimed, Inc. reported inducement grants under Nasdaq Listing Rule 5635(c)(4). The company is a late-stage clinical pharmaceutical company focused on sleep-related breathing disorders.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Apnimed reports inducement grants under Nasdaq Rule 5635(c)(4)
Apnimed, Inc. reports inducement grants under Nasdaq Listing Rule 5635(c)(4).